Regulated Information

Filter

Period

Filter by

Reset

Showing: 1 – 05 of 153 Regulated Information

Show

Sort

Ipsen reports solid sales growth in first quarter 2020 with limited COVID-19 impact

22 April 2020

Ipsen reports solid sales growth in first quarter 2020 with limited COVID-19 impact

Paris (France), 22 April 2020 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced its sales for the first quarter of 2020.

Ipsen presents its 2019 results, provides 2020 guidance and updates 2022 financial outlook

13 February 2020

Ipsen presents its 2019 results, provides 2020 guidance and updates 2022 financial outlook

Paris (France), 13 February 2020 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced its financial results for the full year 2019.